BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 16181385)

  • 1. Biochemical assessment of niacin deficiency among carcinoid cancer patients.
    Shah GM; Shah RG; Veillette H; Kirkland JB; Pasieka JL; Warner RR
    Am J Gastroenterol; 2005 Oct; 100(10):2307-14. PubMed ID: 16181385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors.
    Feldman JM
    Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low plasma tryptophan in carcinoid patients is associated with increased urinary cortisol excretion.
    Tanke MA; Kema IP; Dijck-Brouwer J; Doornbos B; De Vries EG; Korf J
    Psychoneuroendocrinology; 2008 Oct; 33(9):1297-301. PubMed ID: 18722719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients.
    van Dijk SC; de Herder WW; Kwekkeboom DJ; Zillikens MC; Feelders RA; van Schaik RH; van Driel M; van Leeuwen JP
    Bone; 2012 Jun; 50(6):1260-5. PubMed ID: 22425693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary free cortisol excretion in patients with hyperserotoninaemia from the carcinoid syndrome.
    Feldman JM
    Clin Endocrinol (Oxf); 1979 Nov; 11(5):541-8. PubMed ID: 316372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoid and carcinoid syndrome].
    Sukhareva GV; Khomeriki SG
    Eksp Klin Gastroenterol; 2008; (3):110-9. PubMed ID: 19145891
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
    Oberg K; Funa K; Alm G
    N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of tryptophan and albumin metabolism in a patient with carcinoid syndrome, pellagra, and hypoproteinemia.
    Swain CP; Tavill AS; Neale G
    Gastroenterology; 1976 Sep; 71(3):484-9. PubMed ID: 133045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing features of idiopathic flushing and carcinoid syndrome.
    Aldrich LB; Moattari AR; Vinik AI
    Arch Intern Med; 1988 Dec; 148(12):2614-8. PubMed ID: 2461688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sex hormones on the metabolism of tryptophan to niacin and to serotonin in male rats.
    Shibata K; Toda S
    Biosci Biotechnol Biochem; 1997 Jul; 61(7):1200-2. PubMed ID: 9255986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bronchial carcinoid and carcinoid syndrome].
    Biriukov IuV; Bassalyk LS; Kulikov LS; Men'shikov VV; Efimov BI
    Sov Med; 1970 Dec; 33(12):39-43. PubMed ID: 5516942
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current views on carcinoid and the carcinoid syndrome].
    Ryss ES
    Klin Med (Mosk); 1971 Jan; 49(1):13-9. PubMed ID: 4396993
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary carcinoid tumor of the bilateral testis associated with carcinoid syndrome.
    Son HY; Ra SW; Jeong JO; Koh EH; Lee HI; Koh JM; Kim WB; Park JY; Shong YK; Lee KU; Kim GS; Kim MS
    Int J Urol; 2004 Nov; 11(11):1041-3. PubMed ID: 15509216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
    Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The enterochromaffin system and clinical consequences of hyperserotonism].
    Kojecký Z; Kodousek R
    Z Gesamte Inn Med; 1971 Mar; 26(5):Suppl:33-6. PubMed ID: 5560777
    [No Abstract]   [Full Text] [Related]  

  • 16. [Carcinoid of the bronchus--a case report].
    Matsuda M
    Gan No Rinsho; 1970 Sep; 16(9):952-4. PubMed ID: 5528966
    [No Abstract]   [Full Text] [Related]  

  • 17. The incidence of elevations in urine 5-hydroxyindoleacetic acid.
    Nuttall KL; Pingree SS
    Ann Clin Lab Sci; 1998; 28(3):167-74. PubMed ID: 9646859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of the malignant carcinoid syndrome.
    Bell HK; Poston GJ; Vora J; Wilson NJ
    Br J Dermatol; 2005 Jan; 152(1):71-5. PubMed ID: 15656803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoid tumors and the carcinoid syndrome.
    Kazi MU; Grover V
    J Am Geriatr Soc; 1969 Aug; 17(8):807-16. PubMed ID: 5801424
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring the treatment of carcinoid disease using blood serotonin and plasma 5-hydroxyindoleacetic acid: three case examples.
    Allen KR; Degg TJ; Anthoney DA; Fitzroy-Smith D
    Ann Clin Biochem; 2007 May; 44(Pt 3):300-7. PubMed ID: 17456301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.